We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Bayer Limited

The Atrium, Blackthorn Road, Dublin 18,
Telephone: +353 1 2999 313
Fax: +353 1 2061 456
Patient Information Leaflet last updated on medicines.ie: 27/10/2016
PIL Angeliq 1 mg / 2 mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 27/10/2016 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 4 - possible side effects
  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision
Updated on 09/06/2015 and displayed until 27/10/2016
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to date of revision
  • Change to improve clarity and readability
Updated on 20/04/2012 and displayed until 09/06/2015
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 13/04/2012 and displayed until 20/04/2012
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 02/12/2011 and displayed until 13/04/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
  • Change to further information section
  • Change to date of revision
  • Change to dosage and administration
Updated on 21/05/2009 and displayed until 02/12/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to improve clarity and readability
Updated on 21/11/2007 and displayed until 21/05/2009
Reasons for adding or updating:
  • Change to marketing authorisation holder
  • Change to name of manufacturer
  • Change to date of revision
Updated on 06/02/2007 and displayed until 21/11/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to side-effects
Updated on 24/08/2006 and displayed until 06/02/2007
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 26/10/2005 and displayed until 24/08/2006
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 05/08/2005 and displayed until 26/10/2005
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 06/05/2005 and displayed until 05/08/2005
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Estradiol Hemihydrate
   Drospirenone